Peptide 3 injections for fat loss: what the evidence shows

What did @dr.ahmedmaher actually say?

The transcript provided for this video is largely unintelligible as rendered in English transliteration, making it impossible to quote the creator directly with any confidence. What we can work with is the caption, which makes three distinct claims: that a peptide described as "Peptide 3" delivered in 40 injections per session can sculpt the body, increase metabolic rate, and tighten skin while reducing cellulite. The hashtags also position this as a "sleeve gastrectomy alternative," which is an extraordinary claim that deserves serious scrutiny.

Because the spoken transcript cannot be reliably interpreted, this fact-check focuses on the caption claims and the category context of peptide therapy. That limitation matters: we are evaluating what was advertised, not necessarily everything that was explained. The caption alone, however, contains enough claims to warrant a thorough review.

Does the science back this up?

On fat metabolism and skin tightening, the evidence for peptides is real but nowhere near as strong as the caption implies. Short answer: some peptides do show metabolic and dermal effects in research, but the clinical data in humans is thin, and "40 injections per session" as a protocol has no standardized basis in published literature.

GHK-Cu, a copper-binding peptide, has demonstrated collagen synthesis stimulation in in vitro and animal studies. Pickart and Margolina (2018, Biomedicines) documented its role in skin remodeling, but the leap from lab data to "cellulite reduction" in a clinical setting is substantial. On the metabolic side, growth hormone secretagogues like CJC-1295 and ipamorelin have shown modest effects on body composition in small human trials, but these are not approved therapies, and the effect sizes are far from "sleeve gastrectomy" territory. Freda et al. (2010, Journal of Clinical Endocrinology and Metabolism) found modest lean mass changes with GH-releasing peptides, not dramatic fat loss.

What did they get wrong (or right)?

The peptide-skin connection is not invented. That part has a legitimate research base, even if the clinical translation is overstated. Peptides like GHK-Cu and certain growth factors do interact with fibroblasts and connective tissue. Giving credit where it is due: peptide therapy for skin quality is an active and credible research area.

What is wrong, and plainly so, is the framing of this as a bariatric surgery alternative. No peptide protocol has been tested head-to-head against sleeve gastrectomy. Bariatric surgery produces 25-35% total body weight loss in most patients with long-term metabolic benefits documented across decades of data. Describing injections as equivalent is not just an overstatement, it is potentially dangerous misdirection for people with obesity-related health conditions who need evidence-based care. The "40 injections per session" claim also lacks any identifiable clinical protocol in peer-reviewed literature, which raises questions about where this number comes from.

What should you actually know?

Peptide therapy sits in a regulatory gray zone in most countries, including Egypt where this creator appears to be based. Many of these compounds are research chemicals, not approved drugs, and their quality, purity, and dosing are not standardized. That does not mean they have no value, but it does mean that dramatic social media claims outpace the actual evidence considerably.

If you are considering peptide injections for body composition, the honest framework is this: some peptides show real biological activity in early research; none have large-scale randomized controlled trial data supporting fat loss comparable to approved medications like GLP-1 agonists (semaglutide, tirzepatide), and none should be positioned as surgery replacements. A provider who makes those comparisons in a caption is selling something. Be skeptical. Ask for the studies behind the protocol before agreeing to 40 injections of anything.